Prominent geneticist nets retraction, two corrections, and a lot of questions

A team led by David Latchman, a geneticist and administrator at University College London, has notched a mysterious retraction in the Journal of Biological Chemistry, and has had 25 more papers questioned on PubPeer. The JBC notice for “Antiapoptotic activity of the free caspase recruitment domain of procaspase-9: A novel endogenous rescue pathway in cell death” is as useless as they come, a … Continue reading Prominent geneticist nets retraction, two corrections, and a lot of questions

What if universities had to agree to refund grants whenever there was a retraction?

We’re pleased to share this guest post from Leonid Schneider, a cell biologist, science journalist and a prolific cartoonist whose work graces our Twitter profile and Facebook page. In it, Schneider argues for a new way to ensure accountability for publicly funded research. It has become clear that scientific dishonesty is rarely sanctioned.  In the worst case scenario, manipulated or … Continue reading What if universities had to agree to refund grants whenever there was a retraction?

PLOS Genetics investigating paper by Ariel Fernandez

Ariel Fernandez‘s list of papers with editorial asterisks next to them grew again this week. Fernandez has had one paper retracted, two papers subject to Expressions of Concern, including one from Nature, and another put on hold over data concerns. He threatened to sue us for covering one of the Expressions of Concern. Here’s the “Notice … Continue reading PLOS Genetics investigating paper by Ariel Fernandez

“Incorrect data” kills apoptosis paper

Frontiers in Pharmacology has retracted a paper on baicalin, an antioxidant sold in health food stores, because it had both “incorrect data and invalid statistical analyses.” A comment on PubPeer notes that one of the figures (see image to the right) contains two similar-looking flow cytometry images labeled with different values, which could be what the … Continue reading “Incorrect data” kills apoptosis paper

Stem cell researchers sue Harvard, claiming faulty investigation lost them job offers

Piero Anversa, a stem cell researcher at the Brigham & Women’s Hospital, and a colleague, Annarosa Leri, have sued Harvard over an investigation into their work that they claim has cost them millions in a forfeited sale of their company, and job offers. The team has had a paper in Circulation retracted, and a paper in … Continue reading Stem cell researchers sue Harvard, claiming faulty investigation lost them job offers

Stem cell researcher Hanna “working…to correct the unfortunate and inadvertent mistakes” in papers

Jacob Hanna of Israel’s Weizmann Institute has been a media darling for years, including as a member of the 2010 Technology Review 30 under 35 for his work with stem cells. However, questions have been mounting about his research, both on PubPeer (which has critical comments for 15 papers he’s an author on) and in other stem cell labs, who have … Continue reading Stem cell researcher Hanna “working…to correct the unfortunate and inadvertent mistakes” in papers

Italian researcher facing criminal charges notches seventh retraction

Alfredo Fusco, a researcher in Italy under criminal investigation, now has a seventh retraction for manipulated images. Here’s the notice for “Retraction: Identification of new high mobility group A1 associated proteins,” to which not all of the authors agreed:

Are lawyers ruining science?

Regular Retraction Watch readers may have noticed that legal issues seem to be popping up more often in the cases we cover. There has been a lawsuit filed against PubPeer commenters, for example, and Nature last month blamed lawyers for delayed and opaque retraction notices. It was those cases and others that prompted us to … Continue reading Are lawyers ruining science?